What Would You Give to Help Your Parent Live Without Pain And Your Kids Remember You as Strong and Active?
Let’s talk about something real.
Have you ever watched your mom struggle to stand up from the couch? Or winced as she said, “I’m fine,” even though you can tell she’s hurting?
Or maybe it’s your dad who’s stopped going on walks…
Your sister who used to run 5Ks but now avoids stairs…
Or maybe it’s you, icing that knee after chasing the kids around the yard.
If you’ve seen someone you love live with chronic pain or lived with it yourself you know what it steals.
It’s not just the movement. It’s the joy.
Now imagine this: What if you could be part of something that gives it back?
This Isn’t Just a Medical Breakthrough. It’s Personal.
In a short but powerful video, a Brazilian Jiu-Jitsu black belt and lifelong athlete shared something vulnerable:
He’s seen more people forced off the mat, not from burnout or boredom but from chronic joint pain.
Osteoarthritis is relentless. It chips away at mobility, and with it, independence. But it doesn’t just affect elite athletes. It affects everyday people, like your mom, your coach, your neighbor… and maybe you.
That’s why he’s now backing Cytonics, a biotech company developing a drug called CYT-108, a therapy designed to go after the actual cause of osteoarthritis… not just cover it up.
And the wild part? It’s based on a protein your body already makes.
The Protein Already Inside You (That Could Change Everything)
It’s called alpha-2-macroglobulin, or A2M for short.
Your body creates it naturally. Its job? To protect your cartilage from enzymes that break it down.
The problem? For most people, not enough of it makes it into your joints. It’s like having a fire extinguisher that’s locked in another room when the kitchen’s on fire.
Cytonics figured out how to fix that. They took the A2M protein, made it stronger, purer, and more precise, then designed a therapy to deliver it directly into the joint.
Their first-generation therapy is already FDA-cleared. Over 10,000 patients have received it. And the results? Eye-opening.
Now they’re taking it a step further with CYT-108, a next-gen version of this therapy, now preparing to enter Phase 2 clinical trials.
For People Who Want to Stay in the Game, Not Sit on the Sidelines
If you’re someone who…
- Wants to be the parent still playing with your kids at 50, 60, 70+
- Values preventative health, not just prescriptions
- Believes in root-cause healing, not just managing symptoms
- Is always thinking about how to keep moving longer, better, pain-free
Then this story should stop you in your tracks.
Because CYT-108 isn’t just another drug. It’s a potential biological defense system against joint breakdown.
As one investor put it: “It’s like self-defense for your cartilage.”
And it’s being built by a team led by Dr. Gaetano Scuderi, Stanford professor, spine surgeon, and yes, a black belt himself. Someone who’s lived on both sides of the problem: as a doctor and a patient.
This Is About Your Portfolio. But It’s Also About Your Principles.
Yes, Cytonics is an investment opportunity. A strong one:
- The OA treatment market is $393 billion
- The biologics market is projected to reach $581 billion by 2026
- Cytonics holds 25+ patents, completed Phase 1 trials, and raised $25M+
- And they’ve done it not with hedge funds, but with 6,000+ everyday investors
But beyond the numbers, this is about something bigger.
It’s about standing up for the people we love. Backing companies doing good work in a broken healthcare system. Helping make healing more available, more personal, and more effective.
And yes, potentially seeing that goodness show up in your returns, too.
So, What Would You Give to Help Someone You Love Live Without Pain?
And what if you didn’t just give… What if you invested?
*Reg A Disclaimer:
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. You may obtain a copy of the offering circular here.